Michael Laposata Receives Champion for Innovation Award
November 14, 2025
-
4 min
Michael Laposata, MD, PhD, has been honored with the 2025 Champion for Innovation Award from the Association for Molecular Pathology (AMP) for his significant impact on laboratory medicine and advocacy against FDA regulations on laboratory-developed tests (LDTs). His legal involvement was crucial in a lawsuit that led to a ruling preserving diagnostic innovation and patient access. The award was presented during AMP's annual meeting in Boston. Laposata's distinguished career includes over 200 publications and esteemed roles in pathology education.
1. Michael Laposata awarded the Champion for Innovation Award (2025). 2. Recognized for contributions to laboratory medicine and advocacy against FDA rules on LDTs. 3. Key role in legal challenge that preserved diagnostic innovation. 4. Over 200 peer-reviewed publications. 5. Former chair of pathology at University of Texas Medical Branch. 6. AMP's annual meeting held in Boston. 7. Multiple prestigious awards in pathology education.
Listen Tab content
